May 26 (SeeNews) - Swedish biotech company Oncopeptides, focused on difficult-to-treat cancers, said on Tuesday it has entered into an agreement with Slovenian pharmaceutical distributor Salus for the distribution and commercialization of its flagship drug Pepaxti in 11 countries in central and eastern Europe.